Uncategorized

The time to consider nominees for the 2019 R&D100 Awards has arrived. Berkeley Lab has enjoyed success in this competition, averaging four winners per year for the last five years: https://ipo.lbl.gov/success-stories/honors-and-awards/ Technologies first made available for sale, license, or use outside the Lab (as in the case of open source software) between January 1, … [Read more...] about Berkeley Lab Nominations for 2019 R&D 100 Awards

DOE's Office of Technology Transitions (OTT) has launched its FY19 Technology Commercialization Fund (TCF) Solicitation. Three Lawrence Berkeley National Laboratory proposals were funded in FY18. An estimated $26.1M to $28.3M is available for FY19. The solicitation is open only to DOE facilities. OTT pre-recorded an informational webinar to provide an overview of the … [Read more...] about FY19 Technology Commercialization Fund (TCF) Solicitation

Berkeley Lab's Intellectual Property Office (IPO) and Energy Technologies Area (ETA) have arranged for full-time LBNL researchers in clean energy, transportation and sustainability issues to attend the VERGE 2018 Summit (Oct. 16-18 in Oakland). DIRECTIONS To use LBNL's Unlimited Group Package code, you must register individually Go here, complete all requested … [Read more...] about 2018 VERGE – Register for LBNL All Access Pass

Berkeley Lab's contribution to the development of nuclear medicine began in the 1930s. John Lawrence, brother of the Lab's founder Ernest Lawrence, treated a leukemia patient with a radioactive isotope in 1936. A year later, researcher Joseph Hamilton was the first to use radioactive tracers to study biological processes in the human body and to address the property -- short … [Read more...] about Berkeley Lab – Birthplace of Nuclear Medicine